Brain and Mind

Post Views: 876
ARCS Australia Brain and Mind Medicinal Cannabis New Content

Medicinal cannabis in Australia Update

By Australian Health Journal — 2 years ago

According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)

Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.

Post Views: 1,674
Brain and Mind Consumers Health Forum of Australia New Content Population Primary Health Royal Australian College for General Practitioners

Calls for National Social Prescribing Scheme

By Australian Health Journal — 2 years ago

The Royal Australian College of General Practitioners (RACGP), Consumers Health Forum of Australia (CHF) and Mental Health Australia are urging the government to implement a national social prescribing scheme to tackle Australia’s mental health and wellbeing crisis.

Mental ill health is a growing problem in Australia and has been made worse by the COVID-19 pandemic. Since 2017, GPs across Australia have rated mental health as the most common presentation they see as part of the RACGP’s annual Health of the Nation survey. Approximately 20% of patients consult their GP for what are primarily social problems.

Post Views: 666
Brain and Mind Depression

AHJ S1E1: Sydney TMS: Transcranial Magnetic Stimulation

By Australian Health Journal — 5 years ago

TMS (Transcranial Magnetic Stimulation) is a mild form of brain stimulation. Magnetic fields, generated by a coil placed on the head, are used to stimulate a small area of the brain. It is a non-invasive procedure that treats the symptoms of depression through the use of magnetic fields that stimulate nerve cells. The stimulation takes 20-30 minutes and given on an outpatient basis. While receiving stimulation, the patient is fully awake.

It can be use to treat patients who have little success with common treatments e.g., medication, psycho-therapy.

Sydney TMS operates 3 clinics in Australia that provide TMS treatment to patients. Founder Dr Jason Pace spoke with Australian Health Journal

Post Views: 614
Augmented Learning Augmented Reality Brain and Mind Education Multiple Sclerosis Technology

AHJ S1E4: Augmented Reality Learning – Inside MS

By Australian Health Journal — 5 years ago

Augmented learning now has application seeing the changes in a patient’s brain with Multiple Sclerosis through MRI data. Australian Health Journal met the people behind the augmented reality visor technology that will soon be used to teach trainee doctors the transitional phases of MS.

The technology has been developed by Novartis and in collaboration with the Sydney Neuroimaging Analysis Centre, located within the University of Sydney’s Brain and Mind Centre and Hatch Australia, a creative design team based in Sydney. To date the technology has been well received by neurology health care specialists attending conferences in Melbourne and in Berlin, Germany. We caught with a demo for all other healthcare professionals at the recent ARCS Conference.

Post Views: 613
Bipolar Disorder Research

AHJ S1E2: Bipolar Disorder Research by Brain Dynamics Centre

By Australian Health Journal — 6 years ago

The Brain Dynamics Centre, part of Westmead Institute for Medical Research held a community day for World Bipolar Day on 30th March 2018.

The event was MCed by Dr Mayuresh Korgaonkar, Research Director of Brain Dynamics Centre and Senior Research Fellow of the University of Sydney.

Mayuresh is managing research through the project “Brain Connectivity Imaging Markers to Confirm Diagnosis for Bipolar vs. Unipolar Depression – A Connectome Approach.”

The bipolar group at Westmead Institute of Medical Research is recruiting participants with bipolar disorder, major depression, and controls for participation in this research.

Scroll to top